3,380
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Risk stratification score screening for infective endocarditis in patients with Gram-positive bacteraemia

ORCID Icon, ORCID Icon & ORCID Icon
Pages 488-496 | Received 09 Dec 2021, Accepted 01 Mar 2022, Published online: 11 Mar 2022

References

  • Olmos C, Vilacosta I, Fernández-Pérez C, et al. The evolving nature of infective endocarditis in Spain: a population-based study (2003 to 2014). J Am Coll Cardiol. 2017;70(22):2795–2804.
  • Asgeirsson H, Thalme A, Weiland O. Staphylococcus aureus bacteraemia and endocarditis – epidemiology and outcome: a review. Infect Dis (Lond). 2018;50(3):175–192.
  • Kim SL, Gordon SM, Shrestha NK. Distribution of streptococcal groups causing infective endocarditis: a descriptive study. Diagn Microbiol Infect Dis. 2018;91(3):269–272.
  • Østergaard L, Bruun NE, Voldstedlund M, et al. Prevalence of infective endocarditis in patients with positive blood cultures: a Danish nationwide study. Eur Heart J. 2019;40(39):3237–3244.
  • Ternhag A, Cederström A, Törner A, et al. A nationwide cohort study of mortality risk and long-term prognosis in infective endocarditis in Sweden. PLoS One. 2013;8(7):e67519.
  • Franklin M, Wailoo A, Dayer M, et al. The cost-effectiveness of antibiotic prophylaxis for patients at risk of infective endocarditis. Circulation. 2016;134(20):1568–1578.
  • Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30(4):633–638.
  • Habib G, Lancellotti P, Antunes MJ, ESC Scientific Document Group, et al. 2015 ESC guidelines for the management of infective endocarditis: the task force for the management of infective endocarditis of the European society of cardiology (ESC). endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36(44):3075–3128.
  • Bai AD, Agarwal A, Steinberg M, et al. Clinical predictors and clinical prediction rules to estimate initial patient risk for infective endocarditis in Staphylococcus aureus bacteraemia: a systematic review and meta-analysis. Clin Microbiol Infect. 2017;23(12):900–906.
  • Holden E, Bashir A, Das I, et al. Staphylococcus aureus bacteraemia in a UK tertiary referral centre: a 'transoesophageal echocardiogram for all' policy. J Antimicrob Chemother. 2014;69(7):1960–1965.
  • Le Moing V, Alla F, Doco-Lecompte T, VIRSTA study group, et al. Staphylococcus aureus bloodstream infection and endocarditis – a prospective cohort study. PLoS One. 2015;10(5):e0127385.
  • Palraj BR, Baddour LM, Hess EP, et al. Predicting risk of endocarditis using a clinical tool (PREDICT): scoring system to guide use of echocardiography in the management of Staphylococcus aureus bacteremia. Clin Infect Dis: Off Publ Infect Dis Soc Am. 2015;61(1):18–28.
  • Tubiana S, Duval X, Alla F, VIRSTA/AEPEI Study Group, et al. The VIRSTA score, a prediction score to estimate risk of infective endocarditis and determine priority for echocardiography in patients with Staphylococcus aureus bacteremia. J Infect. 2016;72(5):544–553.
  • Kahn F, Resman F, Bergmark S, et al. Time to blood culture positivity in Staphylococcus aureus bacteremia to determine risk of infective endocarditis. Clin Microbiol Infect. 2020 27(9):1345.e7–1345.e12.
  • Sunnerhagen T, Törnell A, Vikbrant M, et al. HANDOC: a handy score to determine the need for echocardiography in non-β-hemolytic streptococcal bacteremia. Clin Infect Dis. 2018;66(5):693–698.
  • Bouza E, Kestler M, Beca T, for the Grupo de Apoyo al Manejo de la Endocarditis, et al. The NOVA score: a proposal to reduce the need for transesophageal echocardiography in patients with enterococcal bacteremia. Clin Infect Dis: Off Publ Infect Dis Soc Am. 2015;60(4):528–535.
  • Berge A, Krantz A, Östlund H, et al. The DENOVA score efficiently identifies patients with monomicrobial Enterococcus faecalis bacteremia where echocardiography is not necessary. Infection. 2019;47(1):45–50.
  • Abu Saleh O, Fida M, Asbury K, et al. Prospective validation of PREDICT and its impact on the transesophageal echocardiography use in management of Staphylococcus aureus bacteremia. Clin Infect Dis. 2021;73(7):e1745–e1753.
  • Dahl A, Lauridsen TK, Arpi M, et al. Risk factors of endocarditis in patients with Enterococcus faecalis bacteremia: external validation of the NOVA score. Clin Infect Dis. 2016;63(6):771–775.
  • Sunnerhagen T, Højgaard Andersen M, Bruun NE, et al. External validation of the HANDOC score – high sensitivity to identify patients with non-beta-haemolytic streptococcal endocarditis. Infect Dis. 2020;52(1):54–54.
  • Van Der Vaart TW, Prins JM, Soetekouw R, et al. Prediction rules for ruling out endocarditis in patients with Staphylococcus aureus bacteremia. Clin Infect Dis. 2021;ciab632. DOI:10.1093/cid/ciab632
  • Peinado-Acevedo JS, Hurtado-Guerra JJ, Hincapié C, et al. Validation of VIRSTA and predicting risk of endocarditis using a clinical tool (PREDICT) scores to determine the priority of echocardiography in patients with Staphylococcus aureus bacteremia. Clin Infect Dis. 2021;73(5):e1151–e1157.
  • Lambregts MMC, Molendijk EBD, Meziyerh S, et al. Early differentiation between uncomplicated and complicated Staphylococcus Aureus bacteremia: potential value and limitations of a clinical risk score. Int J Clin Pract. 2020;74(11):e13601.
  • Dajani AS, Taubert KA, Wilson W, et al. Prevention of bacterial endocarditis: recommendations by the American Heart Association. Clin Infect Dis. 1997;25(6):1448–1458.
  • Friedman ND, Kaye KS, Stout JE, et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med. 2002;137(10):791.
  • Quan H, Li B, Couris CM, et al. Updating and validating the Charlson Comorbidity Index and Score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173(6):676–682.
  • Ternavasio-de la Vega HG, Castaño-Romero F, Ragozzino S, et al. The updated Charlson comorbidity index is a useful predictor of mortality in patients with Staphylococcus aureus bacteraemia. Epidemiol Infect. 2018;146(16):2122–2130.
  • Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA: J Am Med Assoc. 2016;315(8):801–810.
  • Dahl A, Iversen K, Tonder N, et al. Prevalence of infective endocarditis in Enterococcus faecalis bacteremia. J Am Coll Cardiol . 2019;74(2):193–201.
  • Oldberg K, Thorén R, Nilson B, et al. Short time to blood culture positivity in Enterococcus faecalis infective endocarditis. Eur J Clin Microbiol Infect Dis. 2021;40(8):1657–1664.
  • Pinholt M, Østergaard C, Arpi M, Danish Collaborative Bacteraemia Network (DACOBAN), et al. Incidence, clinical characteristics and 30-day mortality of enterococcal bacteraemia in Denmark 2006–2009: a population-based cohort study . Clin Microbiol Infect. 2014;20(2):145–151.
  • Urien J, Camus C, Leclercq C, et al. The emergence of Staphylococcus aureus as the primary cause of cardiac device-related infective endocarditis. Infection. 2021;49(5):999–1006.
  • Sainathan S, Andaz S. A systematic review of transesophageal echocardiography-induced esophageal perforation. Echocardiography. 2013;30(8):977–983.